- Report
- October 2023
- 146 Pages
Global
From €3728EUR$4,150USD£3,183GBP
- Report
- January 2025
- 132 Pages
Global
From €853EUR$950USD£729GBP
- Report
- March 2024
- 132 Pages
Global
From €853EUR$950USD£729GBP
- Report
- March 2024
- 132 Pages
Global
From €853EUR$950USD£729GBP
- Report
- March 2024
- 132 Pages
Global
From €853EUR$950USD£729GBP
- Report
- March 2024
- 132 Pages
Global
From €853EUR$950USD£729GBP
- Report
- June 2023
- 132 Pages
Global
From €853EUR$950USD£729GBP
- Report
- February 2022
- 132 Pages
Global
From €763EUR$850USD£652GBP
- Report
- November 2021
- 545 Pages
Global
From €3593EUR$4,000USD£3,068GBP
- Report
- November 2021
- 270 Pages
Global
From €2246EUR$2,500USD£1,918GBP
- Report
- November 2021
- 1112 Pages
Global
From €5389EUR$6,000USD£4,602GBP
- Report
- November 2021
- 1165 Pages
Global
From €5389EUR$6,000USD£4,602GBP
- Book
- October 2020
- 432 Pages
- Book
- June 2019
- 496 Pages
- Book
- October 2013
- 488 Pages
- Book
- May 2012
- 528 Pages

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more